Document is current
Any future updates will be listed below
-
Authors
Diamond, Jennifer R. https://orcid.org/0000-0002-0703-2772
Eckhardt, S. G.
Pitts, Todd M.
van Bokhoven, Adrie
Aisner, Dara
Gustafson, Daniel L.
Capasso, Anna
Sams, Sharon
Kabos, Peter
Zolman, Kathryn
Colvin, Tiffany
Elias, Anthony D.
Storniolo, Anna M.
Schneider, Bryan P.
Gao, Dexiang
Tentler, John J.
Borges, Virginia F.
Miller, Kathy D.
-
Funding
Funding for this research was provided by:
National Cancer Institute (5P30CA046934-25, 1R21CA164617-01A1, 1K23CA172691-01A1)
- License Information
-
More Information
Article History
Received: 11 May 2018
Accepted: 3 July 2018
First Online: 2 August 2018
Ethics approval and consent to participate
: This trial was approved by the Colorado Multiple Institutional Review Board (COMIRB) prior to patient enrollment (COMIRB no. 11-0684).
: Scientific consulting (to SGE) and research funding (to JRD) were provided by CASI Pharmaceuticals.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
